Global Continuous Glucose Monitoring (CGM) Market, By Product Type (Transmitters and Receivers, Insulin Pumps, Sensors), By Application (Diabetic Patients, and Diabetes Critical Care Patients), and By Geography - Trends and Forecast to 2024

Continuous Glucose Monitoring – Live an Uninterrupted Life

Diabetes is a major global concern that, as per International Diabetes Federation (IDF) data, affected around 415 million people in 2015. Effective management of diabetes is vital, especially considering the sedentary lifestyle that most people across the globe have taken up. Continuous glucose monitoring (CGM) systems offer effective solution in diabetes management through continuous real-time glucose monitoring. Increasing awareness, supporting safety evidences for CGM systems and growing demand for point-of-care (POC) devices are major factors driving demand across the globe. However, high prices of these systems and the rather cumbersome experience of wearing of these relatively obtrusive gadgets throughout the day is currently restraining its demand in the low and middle income countries, where there is inadequate penetration of healthcare IT products and services.

The global continuous glucose monitoring market was valued at US$ 2,035.8 million in 2015 and is expected to expand at a CAGR of 24.5% during the period 2016 – 2024.

Figure 1. Global CGM Market Size and Forecast, US$ Million and Y-o-Y Growth (%)

continuous glucose monitoring devices market

 

Source: Coherent Market Insights Analysis (2016)

Sensors to emerge as highest revenue contributor among component segments

Sensors are an integral part of CGM system. The type and sensitivity of the sensor are crucial factors that influence accuracy of sensing glucose level in the interstitial fluid. Although, transmitters hold a dominant share, accounting for over 50% (2015) share of the market, revenue contribution of the sensors segment is expected to increase at a faster growth rate during the forecast period (2016 – 2024).

Rapid increase in demand for CGM devices, especially in emerging economies, is mainly attributed to increasing consumer awareness regarding the importance of monitoring presence of glucose in the body in order to sustain a healthy life

North America and Europe were the largest markets for continuous glucose monitoring, collectively accounting for over 75% share of the global continuous glucose monitoring market in 2015. This was mainly owing to new product launches, rapid adoption of new technologies, and high product awareness in these developed regions. However, with increasing prevalence of diabetes in emerging economies such as India, China, Taiwan, Brazil, South Korea, and South Africa, demand for CGM devices is expected to witness a steep incline in these countries over the forecast period.

According to the International Diabetes Federation (IDF), around 75% of the diabetic population lives in low and middle income countries such as Mexico, India, China, Brazil, Colombia, Libya, Iran, and Turkey. Asia-Pacific accounted for over 50% of the global diabetic population in 2015, with prevalence rate being the highest in China and India. Market penetration in these countries is relatively low, mainly due to high prices of CGM devices. However, the scenario in Asia Pacific region is expected to change in the near future due to increasing patient awareness and decreasing prices of these systems., which would change the industry dynamics and impact the market growth positively, expanding at a CAGR of 15% during the forecast period.

Integration of advanced technologies is expected to provide a competitive edge to CGM device manufacturers

  • Senseonics, Inc. received CE approval for its Eversense CGM system, the world’s first long-term implantable CGM. Eversense system uses a 90-day implanted sensor, while conventional CGM systems rely on five-to-seven day sensor capacity.
  • GlySens implantable continuous glucose monitoring (ICGM) system is undergoing clinical evaluation for safety and accuracy
  • Medtronic, Inc. collaborated with Fitbit to integrate the physical activity data of the Fitbit wearable with the glucose levels in a single application called iPro2 myLog

These new technologies would give Senseonics, Inc., Medtronic, Inc. and GlySens Incorporated a competitive edge over the existing leading players such as Roche Diagnostics, Dexcom Inc., and Bayer AG.

Global players need to explore the untapped geographies and simultaneously should focus on upgrading their CGM technology

Major players in the global continuous glucose monitoring market include Abbott Laboratories, Roche Diagnostics, Dexcom Inc., Bayer AG, Medtronic, Inc., Animas Corporation, Nova Biomedical Corporation, Ypsomed AG, GlySens Incorporated, Insulet Corporation, and Sensionics Incorporated. Technology and price are the main differentiating factors of CGM systems for these companies. With the existing blood glucose monitors being the priority device for diagnosing diabetes and monitoring, CGM device manufacturers need to develop system with equivalent or higher accuracy for detecting diabetes in order to maintain their competitive edge in the market.

Continuous Glucose Monitoring (CGM) systems are the latest advancement in diabetes management. As opposed to conventional systems that allow for one time check of glucose levels, a CGM device notifies the user if the glucose level nears present levels. The device measures glucose from the tissues as opposed to manual testing of blood using a finger-stick glucose meter, helps in identifying glucose levels for a longer time period, while performing different activities.

Market Dynamics demand for point-of-care (POC) diagnostic devices, and growing self-monitoring trends across the globe. According to the International Diabetes Federation (IDF), the global diabetic population in 2015 was 415 million and is expected to reach 642 million by 2040. Increasing awareness about CGM devices among the diabetic population is projected to be a major factor driving demand for the device in the near future. Moreover, patients are increasingly inclined towards real-time health monitoring, which is possible through CGM systems. Conversely, high prices of devices and calibration issues are key challenges that can inhibit market growth. Companies therefore, need to improve upon the accuracy of the device, which in turn would encourage healthcare practitioners to recommend the use of CGM devices among diabetic patients.

Market Taxonomy

This report segments the CGM market on the basis of application, and end user. On the basis of application, the market is segmented into monitoring glucose for diabetes patients and critical care patients. In terms of end user, the global continuous glucose monitoring market is analyzed for hospitals, home and ambulatory health centers.

Key features of the study:

  • This report provides in-depth analysis of the continuous glucose monitoring devices market and provides market size (US$ Million), market volume (Thousand Units), Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2016 – 2024), considering 2015 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides valuable insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • The report takes into account critical limiting factors such as accuracy issues and need for calibrating the device several times a day while analyzing the market value, volume and growth (%) during the forecast period.
  • It includes insights on high prevalence of diabetes, increasing demand for point-of-care diagnostic devices, and increasing self-monitoring trends across the globe
  • It profiles leading players in the global continuous glucose monitoring market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies and future plans
  • Key companies covered as a part of this study include Abbott Laboratories, Roche Diagnostics, Dexcom Inc., Bayer AG, Medtronic, Inc., Animas Corporation, Nova Biomedical Corporation, Ypsomed AG, GlySens Incorporated, Insulet Corporation, and Sensionics Incorporated
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future product launch, technology upgrade, market expansion, and marketing tactics
  • The global continuous glucose monitoring market report caters to various stakeholders in this industry, including investors, raw material manufacturer, contract manufacturer, device manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would greatly benefit in decision making through the various strategy matrices used in analyzing the CGM market

Detailed Segmentation:

  • Global Continuous Glucose Monitoring Market, By Product Type:
    • Transmitters and Receivers
    • Insulin Pumps
    • Sensors
  • Global Continuous Glucose Monitoring Market, By Application:
    • Diabetic Patients
      • Type 1 Diabetes
      • Type 2 Diabetes
    • Critical Care Patients
  • Global Continuous Glucose Monitoring Market, By Geography:
    • North America
      • U.S.
        • By Product Type
          • Transmitters and Receivers
          • Insulin Pumps
          • Sensors
        • By Application
          • Diabetic Patients
            • Type 1 Diabetes
            • Type 2 Diabetes
          • Critical Care Patients
      • Canada
        • By Product Type
          • Transmitters and Receivers
          • Insulin Pumps
          • Sensors
        • By Application
          • Diabetic Patients
            • Type 1 Diabetes
            • Type 2 Diabetes
          • Critical Care Patients
    • Europe
      •  UK
        • By Product Type
          • Transmitters and Receivers
          • Insulin Pumps
          • Sensors
        • By Application
          • Diabetic Patients
            • Type 1 Diabetes
            • Type 2 Diabetes
          • Critical Care Patients
      • Germany
        • By Product Type
          • Transmitters and Receivers
          • Insulin Pumps
          • Sensors
        • By Application
          • Diabetic Patients
            • Type 1 Diabetes
            • Type 2 Diabetes
          • Critical Care Patients
      • Italy
        • By Product Type
          • Transmitters and Receivers
          • Insulin Pumps
          • Sensors
        • By Application
          • Diabetic Patients
            • Type 1 Diabetes
            • Type 2 Diabetes
          • Critical Care Patients
      • France
        • By Product Type
          • Transmitters and Receivers
          • Insulin Pumps
          • Sensors
        • By Application
          • Diabetic Patients
            • Type 1 Diabetes
            • Type 2 Diabetes
          • Critical Care Patients
      • Russia
        • By Product Type
          • Transmitters and Receivers
          • Insulin Pumps
          • Sensors
        • By Application
          • Diabetic Patients
            • Type 1 Diabetes
            • Type 2 Diabetes
          • Critical Care Patients
      • Rest of Europe
        • By Product Type
          • Transmitters and Receivers
          • Insulin Pumps
          • Sensors
        • By Application
          • Diabetic Patients
            • Type 1 Diabetes
            • Type 2 Diabetes
          • Critical Care Patients
    • Asia-Pacific
      • China
        • By Product Type
          • Transmitters and Receivers
          • Insulin Pumps
          • Sensors
        • By Application
          • Diabetic Patients
            • Type 1 Diabetes
            • Type 2 Diabetes
          • Critical Care Patients
      • India
        • By Product Type
          • Transmitters and Receivers
          • Insulin Pumps
          • Sensors
        • By Application
          • Diabetic Patients
            • Type 1 Diabetes
            • Type 2 Diabetes
          • Critical Care Patients
      • Japan
        • By Product Type
          • Transmitters and Receivers
          • Insulin Pumps
          • Sensors
        • By Application
          • Diabetic Patients
            • Type 1 Diabetes
            • Type 2 Diabetes
          • Critical Care Patients
      • ASEAN
        • By Product Type
          • Transmitters and Receivers
          • Insulin Pumps
          • Sensors
        • By Application
          • Diabetic Patients
            • Type 1 Diabetes
            • Type 2 Diabetes
          • Critical Care Patients
      • Australia
        • By Product Type
          • Transmitters and Receivers
          • Insulin Pumps
          • Sensors
        • By Application
          • Diabetic Patients
            • Type 1 Diabetes
            • Type 2 Diabetes
          • Critical Care Patients
      • South Korea
        • By Product Type
          • Transmitters and Receivers
          • Insulin Pumps
          • Sensors
        • By Application
          • Diabetic Patients
            • Type 1 Diabetes
            • Type 2 Diabetes
          • Critical Care Patients
      • Rest of Asia Pacific
        • By Product Type
          • Transmitters and Receivers
          • Insulin Pumps
          • Sensors
        • By Application
          • Diabetic Patients
            • Type 1 Diabetes
            • Type 2 Diabetes
          • Critical Care Patients
    • Latin America
      • Brazil
        • By Product Type
          • Transmitters and Receivers
          • Insulin Pumps
          • Sensors
        • By Application
          • Diabetic Patients
            • Type 1 Diabetes
            • Type 2 Diabetes
          • Critical Care Patients
      • Mexico
        • By Product Type
          • Transmitters and Receivers
          • Insulin Pumps
          • Sensors
        • By Application
          • Diabetic Patients
            • Type 1 Diabetes
            • Type 2 Diabetes
          • Critical Care Patients
      • Rest of Latin America
        • By Product Type
          • Transmitters and Receivers
          • Insulin Pumps
          • Sensors
        • By Application
          • Diabetic Patients
            • Type 1 Diabetes
            • Type 2 Diabetes
          • Critical Care Patients
    • Middle East
      • GCC
        • By Product Type
          • Transmitters and Receivers
          • Insulin Pumps
          • Sensors
        • By Application
          • Diabetic Patients
            • Type 1 Diabetes
            • Type 2 Diabetes
          • Critical Care Patients
      • Israel
        • By Product Type
          • Transmitters and Receivers
          • Insulin Pumps
          • Sensors
        • By Application
          • Diabetic Patients
            • Type 1 Diabetes
            • Type 2 Diabetes
          • Critical Care Patients
    • Africa
      • North Africa
        • By Product Type
          • Transmitters and Receivers
          • Insulin Pumps
          • Sensors
        • By Application
          • Diabetic Patients
            • Type 1 Diabetes
            • Type 2 Diabetes
          • Critical Care Patients
      • Central Africa
        • By Product Type
          • Transmitters and Receivers
          • Insulin Pumps
          • Sensors
        • By Application
          • Diabetic Patients
            • Type 1 Diabetes
            • Type 2 Diabetes
          • Critical Care Patients
      • South Africa
        • By Product Type
          • Transmitters and Receivers
          • Insulin Pumps
          • Sensors
        • By Application
          • Diabetic Patients
            • Type 1 Diabetes
            • Type 2 Diabetes
          • Critical Care Patients
  • Company Profiles
    • Abbott Laboratories*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
      • Future Plans
    • Roche Diagnostics
    • Dexcom, Inc.
    • Bayer AG
    • Medtronic, Inc.
    • Animas Corporation
    • Nova Biomedical Corporation
    • Ypsomed AG
    • GlySens Incorporated
    • Insulet Corporation
    • Senseonics Incorporated

 

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet By Component
      • Market Snippet By Application
      • Market Snippet By End-Use
      • Market Snippet By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
        • Supply Side Drivers
        • Demand Side Drivers
        • Economic Drivers
      • Restraints
      • Market Opportunities
      • Regulatory Scenario
      • Industry Trend
      • Epidemiology/Prevalence/Incidence
      • Merger and Acquisitions
      • New Product Approvals/Launch
      • Promotion and Marketing Initiatives
    • Cost Tier Down Analysis
  4. Global Continuous Glucose Monitoring Market, By Component, 2014 - 2024 (USD Million & ‘Thousand Units)
    • Introduction
      • Market Share Analysis, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, 2014 - 2024
      • Segment Trends
    • Transmitters and Receivers
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million & ‘Thousand Units)
    • Insulin Pumps
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million & ‘Thousand Units)
    • Sensors
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million & ‘Thousand Units)
  5. Global Continuous Glucose Monitoring Market, By Application, 2014 - 2024 (USD Million)
    • Introduction
      • Market Share Analysis, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, 2014 - 2024
      • Segment Trends
    • Diabetic Patients
      • Introduction
      • Market Share Analysis, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, 2014 - 2024
    • Type 1 Diabetic Patients
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million & ‘Thousand Units)
    • Type 2 Diabetic Patients
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million & ‘Thousand Units)
    • Critical Care Patients
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million & ‘Thousand Units)
  6. Global Continuous Glucose Monitoring Market, By End-Use, 2014 - 2024 (USD Million & ‘Thousand Units)
    • Introduction
      • Market Share Analysis, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, 2014 - 2024
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million & ‘Thousand Units)
    • Ambulatory Care Centers
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million & ‘Thousand Units)
    • Home-Care Settings
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD Million & ‘Thousand Units)
  7. Global Continuous Glucose Monitoring Market, By Regions, 2014 - 2024 (USD Million & ‘Thousand Units)
    • Introduction
      • Market Share Analysis, By Region, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, For Regions, 2014 - 2024
    • North America
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • U.S.
          • Country Trends
          • Market Size and Forecast, By Product, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By Application, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By End-Use, 2014 - 2024 (USD Million & ‘Thousand Units)
        • Canada
          • Country Trends
          • Market Size and Forecast, By Product, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By Application, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By End-Use, 2014 - 2024 (USD Million & ‘Thousand Units)
    • Europe
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • U.K.
          • Country Trends
          • Market Size and Forecast, By Product, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By Application, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By End-Use, 2014 - 2024 (USD Million & ‘Thousand Units)
        • Germany
          • Country Trends
          • Market Size and Forecast, By Product, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By Application, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By End-Use, 2014 - 2024 (USD Million & ‘Thousand Units)
        • Italy
          • Country Trends
          • Market Size and Forecast, By Product, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By Application, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By End-Use, 2014 - 2024 (USD Million & ‘Thousand Units)
        • France
          • Country Trends
          • Market Size and Forecast, By Product, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By Application, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By End-Use, 2014 - 2024 (USD Million & ‘Thousand Units)
        • Russia
          • Country Trends
          • Market Size and Forecast, By Product, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By Application, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By End-Use, 2014 - 2024 (USD Million & ‘Thousand Units)
        • Others
          • Country Trends
          • Market Size and Forecast, By Product, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By Application, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By End-Use, 2014 - 2024 (USD Million & ‘Thousand Units)
    • Asia Pacific
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • China
          • Country Trends
          • Market Size and Forecast, By Product, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By Application, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By End-Use, 2014 - 2024 (USD Million & ‘Thousand Units)
        • India
          • Country Trends
          • Market Size and Forecast, By Product, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By Application, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By End-Use, 2014 - 2024 (USD Million & ‘Thousand Units)
        • Japan
          • Country Trends
          • Market Size and Forecast, By Product, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By Application, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By End-Use, 2014 - 2024 (USD Million & ‘Thousand Units)
        • ASEAN
          • Country Trends
          • Market Size and Forecast, By Product, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By Application, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By End-Use, 2014 - 2024 (USD Million & ‘Thousand Units)
        • Australia
          • Country Trends
          • Market Size and Forecast, By Product, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By Application, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By End-Use, 2014 - 2024 (USD Million & ‘Thousand Units)
        • South Korea
          • Country Trends
          • Market Size and Forecast, By Product, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By Application, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By End-Use, 2014 - 2024 (USD Million & ‘Thousand Units)
        • Others
          • Country Trends
          • Market Size and Forecast, By Product, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By Application, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By End-Use, 2014 - 2024 (USD Million & ‘Thousand Units)
    • Latin America
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • Brazil
          • Country Trends
          • Market Size and Forecast, By Product, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By Application, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By End-Use, 2014 - 2024 (USD Million & ‘Thousand Units)
        • Mexico
          • Country Trends
          • Market Size and Forecast, By Product, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By Application, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By End-Use, 2014 - 2024 (USD Million & ‘Thousand Units)
        • Others
          • Country Trends
          • Market Size and Forecast, By Product, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By Application, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By End-Use, 2014 - 2024 (USD Million & ‘Thousand Units)
    • Africa
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • Northern Africa
          • Country Trends
          • Market Size and Forecast, By Product, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By Application, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By End-Use, 2014 - 2024 (USD Million & ‘Thousand Units)
        • Central Africa
          • Country Trends
          • Market Size and Forecast, By Product, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By Application, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By End-Use, 2014 - 2024 (USD Million & ‘Thousand Units)
        • South Africa
          • Country Trends
          • Market Size and Forecast, By Product, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By Application, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By End-Use, 2014 - 2024 (USD Million & ‘Thousand Units)
    • Middle East
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • GCC Countries
          • Country Trends
          • Market Size and Forecast, By Product, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By Application, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By End-Use, 2014 - 2024 (USD Million & ‘Thousand Units)
        • Israel
          • Country Trends
          • Market Size and Forecast, By Product, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By Application, 2014 - 2024 (USD Million & ‘Thousand Units)
          • Market Size and Forecast, By End-Use, 2014 - 2024 (USD Million & ‘Thousand Units)
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis (3x3 Matrix)
    • Company Profiles
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Bayer Ag
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Dexcom, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Glysens Incorporated
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Insulet Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Medtronic, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Nova Biomedical Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Senseonics, Incorporated
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
    • Analyst Views
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 90 market data tables and 40 figures on "Continuous Glucose Monitoring(CGM) Market - Global forecast to 2024”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.